Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass Study
Skerget, S.; Penaherrera, D.; Chari, A.; Jagannath, S.; Siegel, D. S.; Vij, R.; Orloff, G.; Jakubowiak, A.; Niesvizky, R.; Liles, D.; Berdeja, J.; Levy, M.; Wolf, J.; Usmani, S. Z.; The MMRF CoMMpass Network, ; Christofferson, A. W.; Nasser, S.; Aldrich, J. L.; Legendre, C.; Benard, B.; Miller, C.; Turner, B.; Kurdoglu, A.; Washington, M.; Yellapantula, V.; Adkins, J. R.; Cuyugan, L.; Boateng, M.; Helland, A.; Kyman, S.; McDonald, J.; Reiman, R.; Stephenson, K.; Tassone, E.; Blanski, A.; Docter, B.; Kirchhoff, M.; Rohrer, D. C.; D'Agostino, M.; Gamella, M.; Collison, K.; Stumph, J.; Kidd, P.;
Show abstract
Multiple myeloma is a treatable, but currently incurable, hematological malignancy of plasma cells characterized by diverse and complex tumor genetics for which precision medicine approaches to treatment are lacking. The MMRF CoMMpass study is a longitudinal, observational clinical study of newly diagnosed multiple myeloma patients where tumor samples are characterized using whole genome, exome, and RNA sequencing at diagnosis and progression, and clinical data is collected every three months. Analyses of the baseline cohort identified genes that are the target of recurrent gain- and loss-of-function events. Consensus clustering identified 8 and 12 unique copy number and expression subtypes of myeloma, respectively, identifying high- risk genetic subtypes and elucidating many of the molecular underpinnings of these unique biological groups. Analysis of serial samples showed 25.5% of patients transition to a high-risk expression subtype at progression. We observed robust expression of immunotherapy targets in this subtype, suggesting a potential therapeutic option.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes 96%
- Copy number signatures predict chromothripsis and associate with poor clinical outcomes in patients with newly diagnosed multiple myeloma 96%
- Clonal hematopoiesis is associated with risk of severe Covid-19 96%
Similar papers in this journal
Similar papers in this journal
- Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma 97%
- Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged organ-tropism 94%
- Single-cell spatial analysis of tumor immune architecture in diffuse large B cell lymphoma 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.